Brief: Implanet granted ANVISA regulatory approval in Brazil to market the JAZZ Band platform
03/11/2015 17:08
Nov 3 (Reuters) - Implanet SA IMPL.PA :
* Announces that it has received regulatory approval from
the Brazilian National Health Surveillance Agency (ANVISA) to
market its JAZZ Band platform
Source text for Eikon: ID:nBw8J4YFRa
Further company coverage: IMPL.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))